Japan Sacral Neuromodulation Market Size By (Implantable SNS Devices External SNS Devices), And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Japan Sacral Neuromodulation Market Size By (Implantable SNS Devices External SNS Devices), And Forecast
Japan Sacral Neuromodulation Market Size And Forecast
Japan Sacral Neuromodulation Market size was valued at USD 84.8 Million in 2022 and is projected to reach USD 131.4 Million by 2030, growing at a CAGR of 5.68% from 2024 to 2030.
Growth in the market is anticipated to be fueled by improvements in neurostimulation technology, ongoing clinical research, and rising patient and healthcare provider acceptability. The Japan Sacral Neuromodulation Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Japan Sacral Neuromodulation Market Executive Summary
Sacral neuromodulation (SNM), which uses electrical stimulation to tweak the sacral nerves, is a treatment option for some tricky bladder and bowel issues. You might have heard of it because it's been gaining traction in Japan as a way to help people dealing with overactive bladder (OAB), trouble holding urine (urine retention), and fecal incontinence. With bladder and bowel problems becoming more common in Japan, and the population getting older, there's been a real increase in the need for SNM. Think about it – Japan has a large number of older adults, so age-related conditions like OAB and urine retention are more widespread. Plus, both patients and doctors are starting to see the benefits of SNM. It's a less invasive and reversible option compared to bigger surgeries, and it can be a game-changer for those who haven't found relief with other, more conservative treatments.
The regulatory bodies in Japan have approved sacral neuromodulation as a secure and reliable treatment for a variety of illnesses. Before they may be sold and utilised in clinical settings, SNM devices must have clearance from the Pharmaceuticals and Medical Devices Agency (PMDA). Although obtaining regulatory clearance might take some time, businesses with authorized products have an advantage over rivals in the market.
The effectiveness and safety of sacral neuromodulation are still being studied and researched clinically in Japan. SNM may be used to treat a number of medical ailments outside bowel and bladder problems, such as pelvic pain syndromes and fecal incontinence, according to ongoing research. These trials advance our knowledge of SNM’s therapeutic potential and might eventually result in the approval of new indications.
Just like many of the latest medical advances, sacral neuromodulation can be affected by how healthcare is paid for and insured. How much you get back for SNM surgery in Japan? It really depends on your health and the specific device they use. If we want more people to have access to this treatment, we need to make sure the reimbursement situation is good. The Japanese market looks promising, but there are definitely hurdles. We need to better educate both patients and doctors, address money worries, and even consider how Japanese culture might influence treatment choices. But hey, the future looks bright! The market should grow thanks to better technology, more research, and more people accepting the treatment. With an ageing population and more bladder and bowel issues, SNM could really make a big difference in quality of life for patients in Japan.
What's inside a industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Japan Sacral Neuromodulation MarketSegmentation Analysis
The Japan Sacral Neuromodulation market is segmented on the basis of Product.
Japan Sacral Neuromodulation Market, By Product
Implantable SNS Devices
External SNS Devices
To Get a Summarized Market Report By Product-
Implantable SNS Devices accounted for the largest market share of 84.37% in 2022, with a market value of USD 71.6 Million and is projected to grow at a CAGR of 4.72% during the forecast period.
Key Players
The Japan Sacral Neuromodulation market is highly fragmented with the presence of a large number of players in the market. Some of the major companies include Axonics Japan K.K., Boston Scientific Japan K.K., Cyberonics Japan Co., Ltd. (LivaNova), LivaNova Japan K.K., Medtronic Japan Co., Ltd., Miraca Holdings Inc., Nihon Kohden Corporation, Nuvectra Japan, Ltd., St. Jude Medical Japan Co., Ltd. (Abbott), Terumo Corporation.
Key Developments
The r-SNM System, a second-generation implanted neurostimulator, was just released, according to Axonics Modulation Technologies.
Stimgenics, LLC, a business that specialises in creating and marketing a unique spinal cord stimulation (SCS) waveform, was purchased by Medtronic plc.
Report Scope
REPORT ATTRIBUTES
DETAILS
STUDY PERIOD
2019-2030
BASE YEAR
2022
FORECAST PERIOD
2024-2030
HISTORICAL PERIOD
2019-2021
UNIT
Value (USD Million)
KEY COMPANIES PROFILED
Axonics Japan K.K., Boston Scientific Japan K.K., Cyberonics Japan Co., Ltd. (LivaNova), LivaNova Japan K.K., Medtronic Japan Co., Ltd., Miraca Holdings Inc., Nihon Kohden Corporation, Nuvectra Japan, & Others
SEGMENTS COVERED
By ProductÂ
CUSTOMIZATION SCOPE
Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
To Get Customized Report Scope-Â
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly
Reasons to Purchase this Report
We dig into the market with both qualitative and quantitative analysis, breaking it down by segments using both economic and, well, everything else! You'll get solid numbers, with market value (in USD Billion) provided for each segment and sub-segment. We'll point out the region and segment that's predicted to grow the fastest and be the top dog. Our analysis covers each region, highlighting what's being used and what's influencing the market there. We also look at the competitive scene, including market rankings of the big players and their recent moves (new stuff, partnerships, expansions, and acquisitions over the last five years). You'll get detailed company profiles with overviews, insights, product comparisons, and SWOT analyses for those key companies. We'll give you the current and future outlook for the industry, considering recent developments like growth opportunities, drivers, challenges, and restraints in both emerging and developed regions. We also dive deep with Porter's five forces analysis and give you insights into the market through the Value Chain. Plus, you get the full picture of market dynamics, along with the growth opportunities on the horizon. And to top it off, we offer 6 months of analyst support after the sale!
Customization of the Report
• In case of any  please connect with our sales team, who will ensure that your requirements are met.
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
